Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor‐α and melphalan for limb‐threatening soft tissue sarcomaDirk J. Grünhagen, Alexander M.M. Eggermont, Johannes H. W. de Wilt et al.|Cancer|2006Cited by 137
One Hundred Consecutive Isolated Limb Perfusions With TNF-α and Melphalan in Melanoma Patients With Multiple In-Transit MetastasesDirk J. Grünhagen, Alexander M.M. Eggermont, Flávia Brunstein et al.|Annals of Surgery|2004Cited by 125
High positive sentinel node identification rate by EORTC melanoma group protocolAlexander C. J. van Akkooi, Alexander M.M. Eggermont, A.N. van Geel et al.|European Journal of Cancer|2006Cited by 102
Value of Intraoperative Radiotherapy in Locally Advanced Rectal CancerFloris Ferenschild, Johannes H.W. de Wilt, Maarten Vermaas et al.|Diseases of the Colon & Rectum|2006Cited by 74
The palliative value of tumor necrosis factor α‐based isolated limb perfusion in patients with metastatic sarcoma and melanomaDirk J. Grünhagen, Alexander M.M. Eggermont, Johannes H. W. de Wilt et al.|Cancer|2005Cited by 69